Oslo, Norway, 20 January 2014 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces an update to its financial calendar.

The fourth quarter and full year 2013 results will now be published on 5 February 2014, and not on 28 February 2014 as stated in the announcement of 6 November 2013.

###

For further information, please contact:

Oystein Soug +47 90 65 65 25
Chief Financial Officer
Mike Booth +1 646 410 1884
Communications & Corporate Affairs ir@algeta.com:
mailto:ir@algeta.com

About Algeta

Algeta is a company focused on developing, manufacturing and marketing novel targeted therapies for patients with cancer. The company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit www.algeta.com:
http://www.algeta.com/.

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Change to financial calendar:
http://hugin.info/134655/R/1755605/592806.pdf


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Algeta ASA via Globenewswire
HUG#1755605